Previous Close | 137.87 |
Open | 138.87 |
Bid | 137.97 x 100 |
Ask | 138.10 x 100 |
Day's Range | 134.45 - 139.24 |
52 Week Range | 74.75 - 142.00 |
Volume | |
Avg. Volume | 3,087,224 |
Market Cap | 54.656B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 106.16 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
DexCom's (DXCM) first-quarter 2024 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.
Unveiling the Financial Fortitude and Market Dynamics of DexCom Inc (DXCM)